Study of GS-5319 in Adults With Solid Tumors

NCT07128303 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

178

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: GS-5319

Sponsor

Gilead Sciences